Regencell Bioscience Holdings Limited is a bioscience company specializing in the research, development, and commercialization of Traditional Chinese Medicine (TCM) for the treatment of neurocognitive disorders and degenerations, including ADHD and ASD, as well as infectious diseases affecting the immune system, such as COVID-19. The company has completed research studies and is developing liquid-based standardized TCM formulae for the treatment of ADHD and ASD patients. Additionally, Regencell has entered into a joint venture to offer COVID-19 related treatments in various countries.
Headquarters
11/F First Commercial Building, 33-35 Leighton Road
Hong Kong; Hong Kong;
Postal Code: 999077
Contact Details: Purchase the Regencell Bioscience Holdings Ltd. report to view the information.
Website: http://www.regencellbioscience.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service